| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue | 8,171 | 5,711 | 1,479 | | | Gross Profit | (8,171) | (5,711) | (1,479) | | | Operating Expenses | | Research Development | 14,501 |
-
|
-
| | Selling General and Administrative | 3,552 | 2,560 | 1,246 | | Non Recurring |
-
|
-
|
-
| | Others | 124 | 47 | 18 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (26,349) | (8,319) | (2,744) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 334 | 243 | 57 | | Earnings Before Interest And Taxes | (26,015) | (8,076) | (2,687) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (26,015) | (8,076) | (2,687) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (26,015) | (8,076) | (2,687) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (26,015) | (8,076) | (2,687) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($26,015) | ($8,076) | ($2,687) |
|
0.63% Nasdaq 
0.03%
Income Statement
